DRONTAL PLUS FLAVOUR TABLETS FOR DOGS

国: アイルランド

言語: 英語

ソース: HPRA (Health Products Regulatory Authority)

即購入

製品の特徴 製品の特徴 (SPC)
13-05-2017

有効成分:

PRAZIQUANTEL, PYRANTEL EMBONATE, FEBANTEL

から入手可能:

Bayer Limited

ATCコード:

QP52AF30

INN(国際名):

PRAZIQUANTEL, PYRANTEL EMBONATE, FEBANTEL

投薬量:

50/144/150

医薬品形態:

Tablets

処方タイプ:

CAM-Companion Animal Medicine

治療群:

Canine

治療領域:

Combinations of tetrahydropyrimidines

適応症:

Endoparasiticide

認証ステータス:

Authorised

承認日:

2009-01-25

製品の特徴

                                SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Drontal Plus Flavour Tablets for Dogs
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
3 PHARMACEUTICAL FORM
Tablet.
A light brown to brown, round, flat tablet, cross scored on one side
for oral administration to dogs.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Dogs.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For the control of the following gastrointestinal tapeworms and
roundworms in dogs and puppies.
Ascarids:
_Toxocara canis, Toxascaris leonina_ (adult and late immature forms).
Hookworms:
_Uncinaria stenocephala, Ancylostoma caninum_ (adults)
Whipworms:
_Trichuris vulpis_ (adults)
Tapeworms:
_Echinococcus_ spp.,_ Taenia_ spp.,_ Dipylidium caninum_ (adult and
immature forms)
4.3 CONTRAINDICATIONS
Do not use simultaneously with piperazine compounds.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
As a precautionary measure to prevent
establishment
of
_Echinococcus multilocularis_
in the UK and Ireland it
is
recommended that all dogs and cats entering the country be treated
with praziquantel.
Fleas serve as intermediate hosts for one common type of
tapeworm-_Dipylidium caninum_.
Tapeworm infestation is
certain to re-occur unless control of intermediate hosts such as
fleas, mice etc is undertaken.
Each tablet contains:
mg per tablet
Febantel
150.0
Pyrantel embonate
144.0
Praziquantel
50.0
EXCIPIENTS
Artificial beef flavour, irradiated
116.5
For the full list of excipients see section 6.1.
H
E
A
L
T
H
P
R
O
D
U
C
T
S
R
E
G
U
L
A
T
O
R
Y
A
U
T
H
O
R
I
T
Y
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
_D_
_a_
_t_
_e_
_ 
                                
                                完全なドキュメントを読む